Evidence map›Paper›PMID 40764064›Full record

ArticleJMIR formative research2025

Digital Media Coverage of Respiratory Syncytial Virus-Related News in India: Mixed Methods Content Analysis of Disease Burden and Intervention.

Rhythm Hora, Arindam Ray, Amrita Kumari, Rashmi Mehra, Amanjot Kaur, Syed F Quadri, Bodhisatwa Ray, Seema Singh Koshal, Shyam Kumar Singh, Abida Sultana and 1 more

Abstract read
In one paragraph

Article in JMIR formative research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Rhythm Hora *1, John Snow India, Plot No.5 & 6, LSC Shopping Complex, Nelson Mandela Marg, Vasant Kunj, New Delhi, 110070, India, 91 9368096447.ORCID 0000-0002-0370-6864
Arindam Ray *Gates Foundation, Seattle, WA, United States.ORCID 0000-0002-5955-0352
Amrita Kumari *Gates Foundation, Seattle, WA, United States.ORCID 0000-0002-7956-8373
Rashmi Mehra *1, John Snow India, Plot No.5 & 6, LSC Shopping Complex, Nelson Mandela Marg, Vasant Kunj, New Delhi, 110070, India, 91 9368096447.ORCID 0000-0002-0483-5609
Amanjot Kaur *1, John Snow India, Plot No.5 & 6, LSC Shopping Complex, Nelson Mandela Marg, Vasant Kunj, New Delhi, 110070, India, 91 9368096447.ORCID 0000-0001-5772-0218
Syed F Quadri1, John Snow India, Plot No.5 & 6, LSC Shopping Complex, Nelson Mandela Marg, Vasant Kunj, New Delhi, 110070, India, 91 9368096447.ORCID 0000-0001-9639-2499
Bodhisatwa Ray *University of Exeter, Exeter, United Kingdom.ORCID 0009-0008-5134-9444
Seema Singh Koshal *1, John Snow India, Plot No.5 & 6, LSC Shopping Complex, Nelson Mandela Marg, Vasant Kunj, New Delhi, 110070, India, 91 9368096447.ORCID 0000-0003-3349-9744
Shyam Kumar Singh1, John Snow India, Plot No.5 & 6, LSC Shopping Complex, Nelson Mandela Marg, Vasant Kunj, New Delhi, 110070, India, 91 9368096447.ORCID 0009-0009-6498-4209
Abida Sultana *1, John Snow India, Plot No.5 & 6, LSC Shopping Complex, Nelson Mandela Marg, Vasant Kunj, New Delhi, 110070, India, 91 9368096447.ORCID 0009-0009-7632-3619
Arup Deb Roy *1, John Snow India, Plot No.5 & 6, LSC Shopping Complex, Nelson Mandela Marg, Vasant Kunj, New Delhi, 110070, India, 91 9368096447.ORCID 0000-0001-9569-3396

Funding

Gates Foundation 030655
6 · The paper itself

Abstract

Background: Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in children younger than 5 years of age. Given the high morbidity and mortality associated with RSV in India, the introduction of a vaccine against RSV will potentially reduce the disease's burden. However, vaccine acceptance is influenced by public perception, which is shaped by information disseminated through media sources. This study aims to explore the landscape of RSV-related news coverage in India's digital media. Objective: This study aims to conduct a comprehensive content analysis to explore the landscape of RSV-related news coverage in India's digital media. Methods: Media content analysis was retrospectively conducted by a digital search for all related news pieces in the trustworthy brands of 4 trusted newspapers (Hindustan Times, The Hindu, The Indian Express, and The Times of India) and 3 news channel websites (India Today, NDTV news, and News 18), between November 1, 2022, and October 31, 2023. A total of 58 news pieces were retrieved using selected keywords, with inclusion criteria encompassing English-language news pieces with RSV-specific content. Two reviewers compiled, coded, and analyzed the content. Quantitative data were analyzed descriptively, while qualitative content analysis assessed the emotional tone and sentiment of the pieces. Results: The findings revealed significant digital media coverage on RSV infection and the potential vaccines. The majority of news pieces (53/58, 91%) discussed RSV signs and symptoms, with 64% (37/58) addressing the disease severity and 36% (21/58) highlighting its seasonal surge. However, only 5% (3/58) focused on diagnostic aids. Additionally, 41% (24/58) of news pieces discussed RSV in the context of COVID-19. Regarding the vaccine, 29% (17/58) of news pieces mentioned it, with 26% (15/58) highlighting manufacturers such as Pfizer and GlaxoSmithKline (GSK). Positive sentiment was found in 35% (20/58) of news pieces, while 43% (25/58) exhibited negative sentiment, often related to the disease burden and severity. Emotional tone analysis revealed that 74% (43/58) of news pieces contained emotional elements, with 58% (25/43) expressing negative emotions (eg, concern and anxiety), particularly about hospitalizations and deaths. In contrast, a positive tone was emulated in the frequent mentions of the RSV vaccines as safe, effective, and approved. Conclusions: The analysis revealed significant coverage of RSV-related news in India's digital media, with a focus on disease severity and hospitalizations. While positive sentiment was expressed in coverage of the RSV vaccine, negative sentiments dominated discussions on the disease burden. However, considering the limited number of news pieces, the study highlights the need for improved media coverage to raise awareness about the disease and its preventive strategies. Further research should explore the implications of the overlap between RSV and COVID-19 in media coverage and the limited focus on RSV diagnostics, with a focus on understanding how these factors impact public health outcomes.

Indexed as

Mass MediaRespiratory Syncytial Virus InfectionsCost of IllnessCOVID-19Digital MediaHumansIndiaNewspapers as TopicRespiratory Syncytial Virus VaccinesRetrospective StudiesSocial MediaRespiratory Syncytial Virus Vaccinesdigital mediapublic healthrespiratory syncytial virusrespiratory syncytial virus vaccineRSVvaccine content analysis

Identifiers

PMID40764064
PMCPMC12324896

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.